Review Article
The impact of weight gain associated with atypical antipsychotic use in schizophrenia
- Pierre Chue, Raphael Cheung
-
- Published online by Cambridge University Press:
- 24 June 2014, pp. 113-123
-
- Article
- Export citation
-
Background:
Atypical antipsychotics offer clear advantages in the management of schizophrenia, compared with conventional neuroleptics, but weight gain is a significant adverse effect with some of these agents.
Objective:To review the literature on weight gain associated with atypical antipsychotic treatment in schizophrenia.
Methods:Relevant sources were identified from Medline searches to February 2003 using combinations of keywords including ‘schizophrenia’, ‘antipsychotics’, ‘weight gain’, ‘adverse events’, ‘obesity’, and ‘diabetes’.
Results:Most atypical antipsychotics induce some weight gain, but the magnitude of the effect varies markedly. The greatest increases are seen with clozapine and olanzapine: risperidone has a slight effect, comparable with that of conventional neuroleptics, while ziprasidone and aripiprazole appear from current data to have little effect. In addition, atypical antipsychotics have been associated with metabolic disturbances, particularly glucose dysregulation and dyslipidemia. These effects tend to be more marked with olanzapine and clozapine than with other agents. Weight gain associated with atypical antipsychotics imposes substantial morbidity, in addition to that associated with schizophrenia itself. Furthermore, weight gain can significantly impair patients' quality of life, and leads to non-adherence with treatment. Effective weight management should include the selection of an appropriate atypical antipsychotic and for effective weight management, as well both diet and exercise, formal weight management programs tailored to the needs of schizophrenic patients may be useful, and some patients may benefit from weight-reducing drugs.
Conclusions:Weight gain associated with atypical antipsychotics is a common problem that requires effective management. The selection of an agent with a low risk of weight gain, such as risperidone or ziprasidone, is central to such management.
Original Article
Characteristics of sleep disturbances in Poland – results of the National Health Interview Survey
- Andrzej Kiejna, Joanna Rymaszewska, Bogdan Wojtyniak, Jakub Stokwiszewski
-
- Published online by Cambridge University Press:
- 24 June 2014, pp. 124-129
-
- Article
- Export citation
-
Background:
Apart from insomnia, poor quality of sleep, decreased sleep duration, tiredness after awakening and frequency of using sleeping drugs are important indicators of sleep problems.
Objectives:The aim of this study was to assess the prevalence of indicators of sleep disturbance, such as quality of sleep, sleep duration, feeling of restfulness in the morning and drug utilization in a randomly selected Polish adult population.
Methods:A stratified scheme of sampling involving two steps was used. A representative Polish population sample of 47 924 non-institutionalized adults was interviewed. Assessments of sleep-related problems were based on six questions. Standardized prevalence ratios (SPRs and their 95% confidence intervals) were calculated.
Results:Almost one-tenth of Polish inhabitants usually slept badly or very badly, a problem that was more common among women than men. Quality of sleep decreased together with ageing and this process was more rapid in women than in men over 40 years of age. Highly educated respondents had the highest quality of sleep. Up to one-fifth of the general Polish population usually woke up tired in the morning. Mean sleep duration was 7.7 h, with no gender differences. Usage of over-the-counter (OTC) medications was significantly lower than usage of those prescribed by the physician (5 vs. 16%). Women used OTC drugs twice as often as men.
Conclusions:It would appear to be necessary to introduce educational programmes for the community as well as for general practitioners in order to correct improper attitudes.
Effects of desmopressin (DDAVP) on memory impairment following electroconvulsive therapy (ECT)
- Ebrahim Abdollahian, Mohammad R. Sargolzaee, Moosareza Hajzade, Mohammad D. Mohebbi, Arash Javanbakht
-
- Published online by Cambridge University Press:
- 24 June 2014, pp. 130-137
-
- Article
- Export citation
-
Background:
Memory impairment is a common adverse effect of electroconvulsive therapy (ECT). Studies on animals and humans suggest that vasopressin improves the cognitive function, and positive effects of desmopressin on memory and learning have been reported. This research was performed for evaluation of the effects of desmopressin in the prevention of memory impairment following ECT.
Methods:This randomized, double-blind controlled clinical trial with placebo administration was performed on 50 patients with psychiatric disorders who were candidates for ECT. Subjects in the case group received 60 µm of intranasal desmopressin daily (in three doses of 20 µm). For the control group 0.9% saline solution was administered in the same way. Memory function was evaluated using Wechsler's Memory Scale three times a week (the first time before the start of ECT and the second and third times after the third and sixth sessions, respectively). Results were analyzed by t-test and Paired t-test.
Results:The mean age of patients was 29 years (range 20–40). During the course of ECT, patients in the control group demonstrated a meaningful decrease in memory scores (from a base score of 80.15–75.45 in the second test and 72.60 in the third test). Despite this, a meaningful increase in memory scores was observed during the treatment with desmopressin in the case group (from a base score of 73.27–75.70 and 79.13 in the second and the third tests, respectively). There was a meaningful difference between the two groups (P < 0.0001).
Conclusion:This study confirms the protective effect of desmopressin against memory impairment. The results confirm that memory impairment is a common side-effect of ECT and suggest that desmopressin may prevent ECT-induced memory impairment by its effects on memory and the learning process.
Changes in appearance and schizotypy in normal subjects
- Joost à Campo, Henk Nijman, Harald Merckelbach
-
- Published online by Cambridge University Press:
- 24 June 2014, pp. 138-141
-
- Article
- Export citation
-
Background:
Anecdotal reports suggest that drastic changes in physical appearance may signal psychotic decompensation in schizophrenic patients.
Objective:The current study sought to explore the association between changes in appearance and psychotic vulnerability in a more systematic fashion.
Methods:A sample of undergraduates (n = 171) completed the Changes in Appearance Scale (CAS), which assesses frequency and nature of changes in outlook, along with a Schizotypy Scale (STA), the Maudsley Obsessive Compulsive Inventory (MOCI), the Fear Questionnaire (FQ) and the Beck Depression Inventory (BDI).
Results:A modest but significant correlation was found between the CAS and STA scores. For the other symptom measures (MOCI, FQ, and BDI), no association with self-reported changes in physical appearance emerged.
Conclusions:Changes in physical appearance are found to be significantly associated to mild (pre)psychotic symptoms.
Focus on fillings: a qualitative health study of people medically diagnosed with mercury poisoning, linked to dental amalgam
- Linda Miriam Jones
-
- Published online by Cambridge University Press:
- 24 June 2014, pp. 142-148
-
- Article
- Export citation
-
Background:
This paper reports a qualitative investigation of people who have considered removing their dental amalgam fillings following a medical diagnosis of mercury poisoning.
Objective:To document themes from patients' collective, subjective experience; and explore links between illness and dental amalgam.
Methods:Seven focus groups involved 35 participants selected by random, criteria sampling from the computerized patient records of one medical practice.
Results:The participants' experiences represented four scenarios, each with a distinct pattern of presenting illness, and developmental path for health beliefs linking mercury and illness. When discussing health outcomes following their diagnosis of mercury poisoning, 29 of the 32 participants who had begun amalgam removal reported enduring health gains. Participants compared sources of information on mercury poisoning, and explored issues related to medical practice: the focus on symptoms and not aetiology; how symptoms were monitored; the stigma of a psychosomatic label; suicide; and the problematic detoxification process.
Conclusion:The placebo effect and reduced galvanism as explanations for recovery are considered. A ‘toothless body’ metaphor is proposed as a possible explanation for missed diagnosis of mercury poisoning. Participants reported that the experience was costly both financially and socially, and wanted health professionals to be more open to considering mercury in a causal role for chronic illness.
Differential impairment of working memory performance in first-degree relatives of individuals with schizophrenia
- Aaron R. Kent, Allison M. Fox, Patricia T. Michie, Assen V. Jablensky
-
- Published online by Cambridge University Press:
- 24 June 2014, pp. 149-153
-
- Article
- Export citation
-
Background:
Numerous studies have reported neuropsychological impairment in schizophrenia and increasing evidence suggests that individuals with schizophrenia or schizophrenia spectrum disorders and their unaffected first-degree family members exhibit similar deficits in some neuropsychological domains. Substantial modifications to the Wechsler Memory Scale (WMS) have resulted in more sensitive and reliable indicators of various aspects of memory functioning in the WMS-III, which enables generation of auditory, visual and working memory indices.
Objective:The aim of the present study was to examine the memory profile of individuals with schizophrenia or schizophrenia spectrum disorder (n = 19), their unaffected first-degree family members (n = 11), and healthy controls (n = 9).
Methods:The study involved neuropsychological testing, including the immediate and working memory subtests of the WMS-III, utilizing both auditory and visual domains. Symptom assessment was performed using the Schedules for Clinical Assessment in Neuropsychiatry (SCAN), version 2.0. Two multivariate analyses of covariance (mancova) were conducted: (i) comparing patients, relatives and controls; and (ii) comparing relatives and controls only.
Results:The first analysis indicated that the patient group obtained significantly lower index scores than both relatives and controls on all three indices. The second analysis indicated that the performance of relatives was significantly lower than controls on the working memory index, although there were no significant differences on the auditory and visual immediate index scores.
Conclusions:The differential impairment in working memory performance in clinically asymptomatic family members suggests that the WMS-III working memory index score may be a potential phenotypic marker of schizophrenia.
Abnormal speech perception in schizophrenia with auditory hallucinations
- Seung-Hwan Lee, Young-Cho Chung, Jong-Chul Yang, Yong-Ku Kim, Kwang-Yoon Suh
-
- Published online by Cambridge University Press:
- 24 June 2014, pp. 154-159
-
- Article
- Export citation
-
Background:
The neurobiological mechanism of auditory hallucination (AH) in schizophrenia remains elusive, but AH can be caused by the abnormality in the speech perception system based on the speech perception neural network model.
Objectives:The purpose of this study was to investigate whether schizophrenic patients with AH have the speech processing impairment as compared with schizophrenic patients without AH, and whether the speech perception ability could be improved after AH had subsided.
Methods:Twenty-four schizophrenic patients with AH were compared with 25 schizophrenic patients without AH. Narrative speech perception was assessed using a masked speech tracking (MST) task with three levels of superimposed phonetic noise. Sentence repetition task (SRT) and auditory continuous performance task (CPT) were used to assess grammar-dependent verbal working memory and non-language attention, respectively. These tests were measured before and after treatment in both groups.
Results:Before treatment, schizophrenic patients with AH showed significant impairments in MST compared with those without AH. There were no significant differences in SRT and CPT correct (CPT-C) rates between both groups, but CPT incorrect (CPT-I) rate showed a significant difference. The low-score CPI-I group showed a significant difference in MST performance between the two groups, while the high-score CPI-I group did not. After treatment (after AH subsided), the hallucinating schizophrenic patients still had significant impairment in MST performance compared with non-hallucinating schizophrenic patients.
Conclusions:Our results support the claim that schizophrenic patients with AH are likely to have a disturbance of the speech perception system. Moreover, our data suggest that non-language attention might be a key factor influencing speech perception ability and that speech perception dysfunction might be a trait marker in schizophrenia with AH.
Hypothalamic digoxin, hemispheric chemical dominance and sarcoidosis
- A. Ravi Kumar, Parameswara Achutha Kurup
-
- Published online by Cambridge University Press:
- 24 June 2014, pp. 160-168
-
- Article
- Export citation
-
Background/aims:
The isoprenoid pathway produces three key metabolites: endogenous digoxin (membrane sodium-potassium ATPase inhibitor, immunomodulator and regulator of neurotransmitter/amino acid transport), dolichol (regulates N-glycosylation of proteins) and ubiquinone (free radical scavenger). The role of the isoprenoid pathway in the pathogenesis of sarcoidosis in relation to hemispheric dominance was studied.
Methods:The isoprenoid pathway-related cascade was assessed in patients with systemic sarcoidosis with pulmonary involvement. The pathway was also assessed in patients with right hemispheric, left hemispheric and bihemispheric dominance for comparison to find out the role of hemispheric dominance in the pathogenesis of sarcoidosis.
Results:In patients with sarcoidosis there was elevated digoxin synthesis, increased dolichol and glycoconjugate levels and low ubiquinone and elevated free radical levels. There was also an increase in tryptophan catabolites and a reduction in tyrosine catabolites. There was an increase in the cholesterol:phospholipid ratio and a reduction in the glycoconjugate level of red blood cell (RBC) membrane in this group of patients. The same biochemical patterns were obtained in individuals with right hemispheric dominance. In individuals with left hemispheric dominance the patterns were reversed.
Conclusions:Endogenous digoxin, by activating the calcineurin signal transduction pathway of T cells, can contribute to immune activation in sarcoidosis. An altered glycoconjugate metabolism can lead to the generation of endogenous self-glycoprotein antigens in the lung as well as other tissues. Increased free radical generation can also lead to immune activation. The role of a dysfunctional isoprenoid pathway and endogenous digoxin in the pathogenesis of sarcoidosis in relation to right hemispheric chemical dominance is discussed. All the patients with sarcoidosis were right-handed/left hemispheric dominant according to the dichotic listening test, but their biochemical patterns were suggestive of right hemispheric chemical dominance. Hemispheric chemical dominance has no correlation with handedness or the dichotic listening test.
Temperament and Character Inventory (TCI) in adolescents with anorexia nervosa
- Filip Rybakowski, Agnieszka Slopien, Marzena Zakrzewska, Elzbieta Hornowska, Andrzej Rajewski
-
- Published online by Cambridge University Press:
- 24 June 2014, pp. 169-174
-
- Article
- Export citation
-
Background:
Female patients with anorexia nervosa differ significantly from the control women in various dimensions of personality.
Objective:To investigate the personality dimensions measured with the Temperament and Character Inventory (TCI) in adolescent patients with restrictive-type and bulimic/purging-type anorexia nervosa (ANR and ANB, respectively), and contrast them with the results of control females.
Methods:Sixty-one patients with anorexia nervosa (36 ANR and 25 ANB) and 60 controls were tested with the TCI. A concomitant assessment of depression, body mass index and age was made to evaluate the possible correlation with personality dimensions.
Results:Adolescent ANR patients scored higher in persistence, harm avoidance and cooperativeness, and lower in novelty seeking and self-transcendence than control women. ANB patients scored in the middle between ANR and control females, but differences did not reach the significance level with either group, except for the self-transcendence dimension where they scored significantly higher than those with ANR.
Conclusions:The deviations in temperamental profile of adolescent ANR are similar to those reported in adult patients. The ANB adolescent patients with anorexia nervosa show less prominent deviations from the personality of control women. With regard to the character dimension of cooperativeness, adolescents with ANR scored higher than controls, in contrast to the observations in adult patients. This may reflect the effect of illness on the development of character.
Personality disorder comorbidity among patients with bipolar I disorder in remission
- Lut Tamam, Nurgul Ozpoyraz, Gonca Karatas
-
- Published online by Cambridge University Press:
- 24 June 2014, pp. 175-180
-
- Article
- Export citation
-
Background:
Comorbid personality disorders have been shown to be a prominent factor affecting symptom severity and course in bipolar disorder (BD) patients. Bipolar patients with personality disorder had more relapses, poorer prognosis and worse treatment response than those without an axis II diagnosis.
Objective:We evaluated the prevalence rate of comorbid personality disorder in 74 bipolar I disorder cases who were in remission and tried to elucidate the possible relationship between comorbid axis II disorders and prognosis, severity and treatment features of BD cases.
Methods:Diagnosis of all personality disorder comorbidities was evaluated using the Structured Clinical Interview for DSM-III-R Axis-II Disorders (SCID-II), while the general psychopathology level was assessed using the Symptom Check List (SCL-90-R). A questionnaire for acquiring sociodemographic and clinical variables was also used.
Results:Sixty-two per cent of bipolar I patients in this sample had at least one comorbid axis II disorder. The most common comorbid cluster of personality disorder was cluster C (48.6%), followed by cluster A (25.7%) and cluster B (20.3%) personality disorders. Assessment of demographic and clinical variables revealed that bipolar patients with comorbid personality disorder were mainly female, had multiple affective episodes, and had attempted suicide more often than patients without personality disorder.
Conclusions:The results of this study suggest that comorbid personality disorder might alter the course of BD and result in a poorer prognosis and more severe psychopathology. Further prospective controlled studies minimizing the bias of interviewers and other confounding factors would help us to understand the pure impact of personality disorder on the course of BD, its prognosis and response to treatment.
Letter to the Editor
Charles Bonnet syndrome and dementia
- Bradley Ng, Daniel Smith
-
- Published online by Cambridge University Press:
- 24 June 2014, pp. 181-182
-
- Article
-
- You have access Access
- HTML
- Export citation
Visual hallucinations in CBS: reply from the author
- Koji Hori, Itaru Tominaga, Toshiya Inada, Satoru Sengan, Masayuki Ikeda
-
- Published online by Cambridge University Press:
- 24 June 2014, pp. 183-184
-
- Article
-
- You have access Access
- HTML
- Export citation